Kirkie Maswoswe is a partner in the firm’s Public M&A/Corporate Governance practice and Global M&A Group. Her practice focuses on representing public and private acquirers and target companies in a variety of domestic and cross-border acquisition and disposition transactions, joint ventures and other corporate matters, as well as investment banks in financial advisory matters. Kirkie has deep public and private M&A expertise across a broad range of industries, including technology, life sciences, real estate and private equity.
Representative Matters
Kirkie has extensive experience handling M&A matters for public and private company clients, including domestic and cross-border acquisitions and dispositions, joint ventures, take-privates, and SPAC transactions. She also advises investment banks in connection with financial advisory matters, and companies and their boards of directors in connection with corporate governance and shareholder activism matters.
Kirkie’s representative experience includes:
- Markforged in its pending $115 million take-private sale to Nano Dimension
- Pathology Watch in its $130 million sale to Sonic Healthcare
- Berkshire Grey in its $375 million take-private sale to SoftBank
- FactSet in its $1.9 billion carve-out acquisition of CUSIP Global Services from S&P Global*
- Genesys in its:
- Carve-out acquisition of the Bold360 business from LogMeIn*
- Acquisitions of Exceed.ai and Pointillist*
- Permira in its significant investments in CommentSold, Click&Boat, and Boats Group*
- LifeLock in its $2.3 billion sale to Symantec*
- Trader Corporation in its $1.6 billion sale to Thoma Bravo*
- Dyn in its sale to Oracle*
- Thomson Reuters in its acquisition of Integration Point*
- Genpact in its $550 million acquisition of Headstrong*
*Denotes experience prior to joining Goodwin
- Novo Holdings in its pending $16.5 billion take-private acquisition of Catalent
- ImmuNext in its $525 million sale to Royalty Pharma
- Novo Holdings in its $462 million take-private acquisition of Paratek Pharmaceuticals with Gurnet Point Capital
- GreenLight Biosciences in its $45.5 million take-private sale to a consortium led by Fall Line
- LumiraDx in its $3 billion de-SPAC merger with CA Healthcare*
- Goldman Sachs as a member of the buyer consortium in its $1.6 billion acquisition of New Frontier Health*
- ImmunityBio in its $3.6 billion merger with NantKwest*
- Synageva BioPharma in its $8.4 billion sale to Alexion Pharmaceuticals*
- Pfizer in its $17 billion acquisition of Hospira*
- Cubist Pharmaceutical in its $9.5 billion sale to Merck*
- Pfizer in its €115 million acquisition of two meningitis vaccines from GlaxoSmithKline*
- Mylan in its acquisition of Synerx Pharma*
*Denotes experience prior to joining Goodwin
- Board of Directors of Home Partners of America in the $6 billion sale of Homes Partners of America to Blackstone*
- Extended Stay in its $6.1 billion sale to Blackstone and Starwood*
*Denotes experience prior to joining Goodwin
- Morgan Stanley as financial advisor to Envestnet in its pending $4.5 billion sale to Bain Capital
- Qatalyst Partners as financial advisor to Alteryx in its $4.4 billion sale to Clearlake Capital Group and Insight Partners
- J.P. Morgan as financial advisor to Flexion Therapeutics in its $630 million sale to Pacira Biosciences*
- Evercore as financial advisor to Canadian Pacific in its $29 billion merger agreement with Kansas City Southern*
- Goldman Sachs as financial advisor to Penn National in its $2 billion acquisition of theScore*
- Lazard as financial advisor to Versum Materials in its $5.8 billion merger with Merck*
- Morgan Stanley as financial advisor to El Paso in its $38 billion merger with Kinder Morgan*
*Denotes experience prior to joining Goodwin
- WHP Global in its transformative strategic transaction with Express and acquisition of Bonobos
- Mondelez in its $30 billion spin-off of Kraft Foods*
- DreamWorks Animation in the formation of Oriental DreamWorks, a China-focused media joint venture, with China Media Capital and Shanghai Media Group*
- Aramex in its $265 million acquisition of MyUS*
- Special Committee of Market Basket in the $1.5 billion shareholder buyout of Market Basket*
- Marquee Brands in its acquisition of Ben Sherman and related IP assets from Oxford Industries*
- BAE Systems in its $114 million sale of Safariland to Kanders*
- Stanley in its $1.1 billion sale to CGI Group*
*Denotes experience prior to joining Goodwin
PROFESSIONAL EXPERIENCE
Prior to joining Goodwin, Kirkie most recently practiced at Cravath, Swaine & Moore LLP. She was also previously an investment banker at Goldman Sachs & Co., where she advised companies in the technology, media and telecommunications sectors.
While in law school, Kirkie was an editor of the Harvard Law Review.
Professional Activities
Credentials
Education
JD2009
Harvard Law School
MBA2009
Harvard Business School
AB2005
Harvard College
(cum laude)
Admissions
Bars
- New York
- Massachusetts
Recognition & Awards
Kirkie was recognized in The Best Lawyers in America, Ones to Watch for Mergers and Acquisitions Law 2025. She was also recognized as a New York Rising Star – Mergers & Acquisitions by Super Lawyers in 2022, 2023 and 2024, and was named to the National Black Lawyers’ Top 100 list in 2022, 20023 and 2024.
Publications
Kirkie’s recent speaking engagements include:
- Speaker, “Private Equity Take-Private Transactions: Deal Structures, Financing Considerations, Advantages and Disadvantages,” Strafford Webinar, October 17, 2024
- Speaker, “M&A in Special Situations,” TechGC M&A Conference, March 5, 2024
- Speaker, “The Power of Black Women Venture Capitalists,” BWAM Annual Conference, November 3, 2023
- Speaker, “Special Committees in Conflicted M&A Transactions: Implementing Processes, Negotiating the Deal, Avoiding Pitfalls,” Strafford Webinar, November 1, 2023
- Speaker, ABA Business Law Fall Meeting, September 7-9, 2023